X-Nico

unusual facts about uterine papillary serous carcinoma



Endometrial cancer

The antibody Herceptin, which is used to treat breast cancers that overexpress the HER2/neu protein, has been tried with some success in a phase II trial in women with uterine papillary serous carcinomas that overexpress HER2/neu.


see also